Natural Choice Distribution Company Inc. Voluntarily Recalls Certain Lots Of Fare And Square Sandwiches, Superfresh Sandwiches, And Real Wraps Burritos Due To The Presence Of Undeclared Allergens

Natural Choice Distribution Company Inc. is recalling certain ready-to-eat sandwiches and wraps because the products’ labels fail to declare food allergens. No illnesses have been reported. People who have allergies to MILK, WHEAT, SOY, OR EGGS run the risk of a serious or life-threatening allergic reaction if they consume these products.

Upsher-Smith Laboratories Announces Expansion of Voluntary Nationwide Recall. Affected Products Include Amantadine, Amlodipine, Androxy, Baclofen, Bethanechol, Jantoven® and Oxybutynin

Upsher-Smith Laboratories, Inc., of Maple Grove, Minnesota is voluntarily expanding its previously announced recall of Jantoven® Warfarin Sodium, USP, 3 mg Tablets to include additional products that were packaged on the same packaging line between
May 17, 2010 and November 17, 2010. The company is initiating the recall as a precautionary measure after a bottle labeled as Jantoven® Warfarin Sodium, USP, 3 mg Tablets was found by a retail pharmacy to contain tablets at a higher, 10 mg strength.

Hua Shing International Trading Corp Issues an Alert on Uneviscerated Fish

HUA SHING INTERNATIONAL TRADING CORP AT 50 ELDRIDGE ST-1FL NEW YORK, NEW YORK, 10002 is recalling FROZEN SCDA (fish) discovered by New York State Department of Agriculture and Markets Food Inspectors during a routine inspection and subsequent analysis of product by Food Laboratory personnel confirming that the fish was not properly eviscerated prior to processing.
This product maybe contaminated with Clostridium botulinum spores, which can cause Botulism, a serious and potentially fatal food –borne illness.
Read The Complete Story!

PHOTO – Hua Shing International Trading Corp Issues an Alert on Uneviscerated Fish

HUA SHING INTERNATIONAL TRADING CORP AT 50 ELDRIDGE ST-1FL NEW YORK, NEW YORK, 10002 is recalling FROZEN SCDA (fish) discovered by New York State Department of Agriculture and Markets Food Inspectors during a routine inspection and subsequent analysis of product by Food Laboratory personnel confirming that the fish was not properly eviscerated prior to processing.
Read The Complete Story!

FDA warns against certain uses of asthma drug terbutaline for preterm labor

The U.S. Food and Drug Administration is warning that terbutaline administered by injection or through an infusion pump should not be used in pregnant women for prevention or prolonged (beyond 48-72 hours) treatment of preterm labor due to the potential for serious maternal heart problems and death. In addition, oral terbutaline tablets should not be used for prevention or treatment of preterm labor. The FDA is requiring the addition of a Boxed Warning and Contraindication to the drug prescribing information (labeling) to warn against these uses.

Upsher-Smith Laboratories Announces The Voluntary Nationwide Recall Of Jantoven® Warfarin Sodium Tablets, USP, 3mg, Due To Mislabeled Bottles

Upsher-Smith Laboratories, Inc., of Maple Grove, Minnesota is voluntarily recalling one lot (lot #284081) of Jantoven® Warfarin Sodium, USP, 3mg Tablets, an anticoagulant with an expiration date of September 2012, NDC # 0832-1214-00. The company is initiating the recall as a precautionary measure after a single bottle labeled as Jantoven® Warfarin Sodium, USP, 3mg Tablets was found to contain tablets at a higher, 10mg strength before it was dispensed.

Prime Choice Foods Corporation Voluntarily Recalls Certain Lots Of Garden Of Eatin’® Multi Grain Tortilla Chips Due To The Presence Of Undeclared Allergens

Prime Choice Foods announced that it is taking the precautionary measure of recalling certain lots of Garden of Eatin’® Multi Grain Sea Salt Tortilla Chips (9 oz bags), Garden of Eatin’® Multi Grain Everything Tortilla Chips (9 oz bags) and Garden of Eatin’® Multi Grain Blues Sea Salt Tortilla Chips (9 oz bags) due to the presence of undeclared wheat and soy.
Consumers who have an allergy or severe sensitivity to wheat or soy run the risk of serious or life-threatening allergic reaction if they consume these products.

FDA seeks to invest in foodborne illness prevention, medical product safety and countermeasures

The U.S. Food and Drug Administration is requesting a budget of $4.3 billion to protect and promote the public health as part of the President’s fiscal year (FY) 2012 budget — a 33 percent increase over the FDA enacted budget for FY 2010. The FY 2012 request covers the period of Oct. 1, 2011, through Sept. 30, 2012.